TickerFacts.

Sunshine Biopharma Inc. (SBFM): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$21.83M
As of 2022-12-31
n/m
3-year compound annual growth
2010-12-31: $162.4K2011-12-31: $60.7K2012-12-31: $132.6K2013-12-31: $31.2K2014-12-31: $143.4K2015-12-31: $50.8K2016-12-31: $57.5K2017-12-31: $107.5K2018-12-31: $110.5K2019-12-31: $40.5K2020-12-31: $989.9K2021-12-31: $2.05M2022-12-31: $21.83M$21.83M
2010-12-31 Cash & Equivalents (USD) 2022-12-31
Period endedCash & EquivalentsChange YoYSource filing
2022-12-31$21.83M+967.2%2023-04-04, Balance as of period end
2021-12-31$2.05M+106.6%2023-04-04, Balance as of period end
2020-12-31$989.9Kn/m2022-03-21, Balance as of period end
2019-12-31$40.5K-63.4%2021-03-30, Balance as of period end
2018-12-31$110.5Kn/c2020-05-01, Balance as of period end
2017-12-31$107.5K+87.2%2019-04-12, Balance as of period end
2016-12-31$57.5K+13.1%2018-04-02, Balance as of period end
2015-12-31$50.8K-64.6%2017-04-17, Balance as of period end
2014-12-31$143.4K+359.1%2016-03-25, Balance as of period end
2013-12-31$31.2K-76.4%2015-03-11, Balance as of period end
2012-12-31$132.6K+118.5%2014-03-19, Balance as of period end
2011-12-31$60.7K-62.6%2013-03-15, Balance as of period end
2010-12-31$162.4Kn/a2012-03-19, Balance as of period end